Caterina Casari – Prizes for Innovators 2025 Winner!
Caterina Casari, Researcher (CRCN) at Inserm, reposted from Soufiane Carcaillet on LinkedIn:
”Today, I had the honor of receiving the Prizes for Innovators 2025.
This award celebrates the collective achievements of an outstanding TEAM at the HITh lab Inserm, with whom I have the privilege to work.
Innovation grows from shared vision, dedication, and collaboration, and I couldn’t wish for a better group.
I warmly thank the Scientific Committee and the Région Ile de France for this recognition, and Nelly GARNIER and Amanda Silva Brun for their kind introduction.
I am deeply grateful to all the TEAM members, colleagues, and mentors who have contributed to this journey – especially Cécile DENIS Peter Lenting Olivier Christophe and Ivan Peyron.
I hope this recognition will also help raise greater visibility for hashtag#vonWillebrandDisease and the patients who suffer from this condition.”
Soufiane Carcaillet, Student Entrepreneurship and Innovation Project Manager – IDF Regional Council, Ile-de-France Region, shared on LinkedIn:
” 2025 Innovators Award
The three winners of the 2025 Région Ile de France Prizes for Innovators awarded by Nelly GARNIER and Amanda Silva Brun during the Medicine Day are:
- First Prize (€50k): Brice Bathellier, CNRS Research Director at the Institut Pasteur, within the Institut de l’Audition. His innovation focuses on the creation of a brain stimulator and deep encoding networks for auditory restoration.
- Second Prize (25k€): Thierry Dufour, Associate Professor at Sorbonne University, in the Plasma Physics Laboratory. Its innovation is a cold plasma endoscopic catheter for the local treatment of digestive cancers.
- Third Prize (€25k): Caterina Casari, INSERM Research Fellow at the Bicêtre Hospital, in the Haemostasis Inflammation Thrombosis laboratory. Her innovation is in the development of a treatment for Willebrand disease, a hereditary hemorrhagic disease.”
Stay updated with Hemostasis Today.
-
Apr 11, 2026, 13:51David McIntosh: Vital Plasma Derived Medicines – The Anomalous UK Scene
-
Apr 11, 2026, 13:47Samrawit Terefe: O Negative Blood Is the Universal Donor With Extreme Scarcity
-
Apr 11, 2026, 13:39Dheeraj Garg: Rethinking Cardiovascular Disease – A Cardiologist’s Perspective
-
Apr 11, 2026, 13:37Kushal Bhatia: Is The 4.5-Hour Thrombolysis Window Officially Outdated?
-
Apr 11, 2026, 13:35William Aird: Why Did Mammalian Red Blood Cells Give Up Their Nucleus?
-
Apr 11, 2026, 13:30Ken Kuang: Gravity Is Constant, But Your Vein Health Doesn’t Have to Be
-
Apr 11, 2026, 13:21Mascha Kern: Measuring Gender’s Role in Stroke and Migraine
-
Apr 11, 2026, 13:10Danique Steeghs: Key Findings from a Microfluidic Chemiluminescent Thrombin Generation Assay
-
Apr 11, 2026, 13:06Shanvi Mahi: A Validated Tool to Explore Lived Experiences After Stroke Rehabilitation